Abstract
Background
In non-arteritic anterior ischemic optic neuropathy (NA-AION), no treatments have demonstrated to be effective in recovering visual loss in randomized clinical trials. Oral steroids have been evaluated, and small series of intravitreal triamcinolone acetonide (IVTA) injection in NA-AION have been reported. The purpose of our study was to report the visual outcome and morphological changes in response to a single IVTA injection as a treatment for patients with NA-AION.
Patients and methods
The charts of 36 patients with visual symptoms and optic disc swelling caused by NA-AION were evaluated. Twenty-one patients had received 4 mg IVTA and were compared with 15 non-treated patients. Visual acuity (VA), retinal nerve fiber layer thickness and static visual field were evaluated after 6 months.
Results
VA improvement at 6 months is statistically better in the treated group than in the non-treated group (p = 0.0035). In the treated group, there was a significant inverse correlation between the delay of the injection and the visual acuity achieved at 6 months (p < 0.0083**, r = −0.56). A significant improvement of the visual field was noted in the injected group when compared with the non-treated group at 6 months (p < 0.0028).
Discussion
In this retrospective study, patients receiving IVTA in the acute phase of NA-AION have better improvement of VA and visual field during the follow-up period of 6 months. However, only a large randomized controlled trial may enable to evaluate the benefits of IVTA Injections on visual outcome in NA-AION.
Similar content being viewed by others
References
Miller GR, Smith JL (1966) Ischemic optic neuropathy. Am J Ophthalmol 62:103–115
Repka MX (1975) Clinical profile and long-term implications of anteriorischemic optic neuropathy. Brain 98:689–708
Olver JM, Spalton DJ, McCarney ACE (1990) Microvascular study of the retrolaminar optic nerve in man. The possible significance in anterior ischaemic optic neuropathy. Eye 4:7–24
Beri M, Klugman MR, Kohler JA, Hayreh SS (1987) Anterior ischemic optic neuropathy VII. Incidence of bilaterality and various influencing factors. Ophthalmology 94:1020–1028
Hayreh SS (1974) Anterior ischaemic optic neuropathy III. Treatment, prophylaxis, and differential diagnosis. Br J Ophthalmol 58:98l–989l
Hayreh SS (1990) Anterior ischaemic optic neuropathy: differentiation of arteritic from non-arteritic type and its management. Eye 4:25–41
Hayreh SS, Podhajsky PA, Zimmerman B (1999) Role of nocturnal arterial hypotension in optic nerve head ischemic disorders. Ophthalmologica 213:76–96
Beck RW, Servais GE, Hayreh SS (1987) Anterior ischemic optic neuropathy IX. Cup-to-disc ratio and its role in pathogenesis. Ophthalmology 94:1503–1508
The Ischemic Optic Neuropathy Decompression Trial Research Group (1995) Optic nerve decompression surgery for nonarteritic anterior ischemic optic neuropathy (NAION) is not effective and may be harmful. JAMA 273:625–632
Newman NJ, Scherer R, Langenberg P, Kelman S, Feldon S, Kaufman D, Dickersin K, Ischemic Optic Neuropathy Decompression Trial Research Group (2002) The fellow eye in NAION: report from the ischemic optic neuropathy decompression trial follow-up study. Am J Ophthalmol 134:317–328
Ischemic Optic Neuropathy Decompression Trial Research Group (2000) Ischemic optic neuropathy decompression trial: twenty-four-month update. Arch Ophthalmol 118:793–798
Beck RW, Hayreh SS, Podhajsky PA, Tan E-S, Moke PS (1997) Aspirin therapy in nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol 123:212–217
Rootman DB, Gill HS, Margolin EA (2013) Intravitreal bevacizumab for the treatment of nonarteritic anterior ischemic optic neuropathy: a prospective trial. Eye (Lond) 27(4):538
Hayreh SS, Zimmerman MB (2008) Non-arteritic anterior ischemic optic neuropathy: role of systemic corticosteroid therapy. Graefes Arch Clin Exp Ophthalmol 246(7):1029
Bailey IL, Lovie JE (1976) New design principles for visual acuity letter charts. Am J Optom Physiol Opt 53(11):740
Colenbrander A (1994) The functional vision score: a coordinated scoring system for visual impairments, disabilities and handicaps. In: Kooijman A et al. (eds) Low vision: Research and new developments in rehabilitation. Studies in Health Technology and Informatics. IOS Press, Amsterdam, p 552
Jonas JB, Degenring RF, Kreissig I, Akkoyun I, Kamppeter BA (2005) Intraocular pressure elevation after intravitreal triamcinolone acetonide injection. Ophthalmology 112(4):593
Vasconcelos-Santos DV, Nehemy PG, Schachat AP, Nehemy MB (2008) Secondary ocular hypertension after intravitreal injection of 4 mg of triamcinolone acetonide: incidence and risk factors. Retina 28(4):573
Hayreh SS, Podhajsky PA, Zimmerman B (1997) Non-arteritic anterior ischemic optic neuropathy—time of onset of visual loss. Am J Ophthalmol 124:641–647
Hayreh SS, Zimmerman B (2008) Non-arteritic anterior ischemic optic neuropathy: natural history of visual outcome. Ophthalmology 115:298–305
Jonas JB, Spandau UH, Harder B, Saunder G (2007) Intravitreal triamcinolone acetonide for treatment of acute nonarteritic anterior ischemic optic neuropathy. Graefes Arch Clin Exp Ophthalmol 245(5):749
Yaman A, Selver OB, Saatci AO, Soylev MF (2008) Intravitreal triamcinolone acetonide injection for acute non-arteritic anterior ischaemic optic neuropathy. Clin Exp Optom 91(6):561–565
Kaderli B, Avci R, Yucel A, Guler K, Gelisken O (2007) Intravitreal triamcinolone improves recovery of visual acuity in nonarteritic anterior ischemic optic neuropathy. J Neuroophthalmol 27:164–168
Sohn BJ, Chun BY, Kwon JY (2009) The effect of an intravitreal triamcinolone acetonide injection for acute nonarteritic anterior ischemic optic neuropathy. Korean J Ophthalmol 23(1):59–61
Hayreh SS (2008) Intravitreal triamcinolone for non-arteritic anterior ischemic optic neuropathy. J Neuroophthalmol 28:77–78
Hayreh SS, Zimmerman MB (2007) Optic disc edema in non-arteritic anterior ischemic optic neuropathy. Graefes Arch Clin Exp Ophthalmol 245:1107–1121
Hayreh SS (1969) Blood supply of the optic nerve head and its role in optic atrophy, glaucoma and oedema of the optic disc. Br J Ophthalmol 53:721–748
Hayreh SS (1978) Fluids in the anterior part of the optic nerve in health and disease. Surv Ophthalmol 23:1–25
Hayreh SS (2001) The blood supply of the optic nerve head and the evaluation of it -Myth and reality. Prog Retin Eye Res 20:563–593
Osako T, Chuman H, Maekubo T (2013) Effects of steroid administration and transcorneal electrical stimulation on the anatomical and electrophysiological deterioration of nonarteritic ischemic optic neuropathy in a rodent model. Jpn J Ophthalmol 57(4):402–409
Chuman H, Kawano N, Kozawa M (2013) Vasodilatory effects of anti-vascular endothelium growth factor (VEGF) antibody, corticosteroid, and nitric oxide on the posterior ciliary artery. Jpn J Ophthalmol 57(3):320–326
Hayreh SS (2005) Prevalent misconceptions about acute retinal vascular occlusive disorders. Prog Retin Eye Res 24:493–519
Hayreh SS, Zimmerman MB, Podhajsky P, Alward WL (1994) Nocturnal arterial hypotension and its role in optic nerve head and ocular ischemic disorders. Am J Ophthalmol 117:603–624
McLeod D, Marshall J, Kohner EM (1980) Role of axoplasmic transport in the pathophysiology of ischaemic disc swelling. Br J Ophthalmol 64:247–261
Kesler A, Irge D, Rogowski O, Bornstein N, Berliner S, Shapira I, Shani ST, Ben Assayag E (2009) High-sensitivity C-reactive protein measurements in patients with non-arteritic anterior ischaemic optic neuropathy: a clue to the presence of a microinflammatory response. Acta Ophthalmol 87(2):216
Hayreh SS (2011) Management of ischemic optic neuropathies. Indian J Ophthalmol 59(2):123–136
Conflicts of Interest
None
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Radoi, C., Garcia, T., Brugniart, C. et al. Intravitreal triamcinolone injections in non-arteritic anterior ischemic optic neuropathy. Graefes Arch Clin Exp Ophthalmol 252, 339–345 (2014). https://doi.org/10.1007/s00417-013-2499-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00417-013-2499-9